Elicio Therapeutics Inc
(ELTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2017 | 12-2006 | |
| Sales | 1,487 | 0 | 0 |
| Cost of Goods | 640 | N/A | N/A |
| Gross Profit | 847 | N/A | N/A |
| Operating Expenses | 40,078 | 0 | 0 |
| Operating Income | -38,591 | N/A | N/A |
| Other Income | -2,067 | 0 | 0 |
| Pre-tax Income | -40,658 | 0 | 0 |
| Net Income Continuous | -40,658 | N/A | N/A |
| Net Income | $-40,658 | $N/A | $N/A |
| EPS Basic Total Ops | -28.20 | N/A | N/A |
| EPS Basic Continuous Ops | -28.17 | N/A | N/A |
| EPS Diluted Total Ops | -28.20 | N/A | N/A |
| EPS Diluted Continuous Ops | -28.17 | N/A | N/A |
| EBITDA(a) | $-38,095 | $N/A | $N/A |